Big news for women fighting advanced womb cancer: the NHS just approved a new treatment called pembrolizumab (aka Keytruda) that’s proven to slow cancer growth and boost survival rates. It’s an immunotherapy given with chemo, and trials show it cuts the risk of death by 26% compared to chemo alone. About 2,100 women a year in England could benefit. This is a major step forward for better outcomes and more time with loved ones! #Health #BodyHealth #CancerTreatment